Temporal determination of lung NO system and COX-2 upregulation following ischemia-reperfusion injury

Experimental Lung Research

Volumn 40, Issue 1, 2014, Pages 22-29

  Dolkart, Oleg ^a   Amar, E ^a   Shapira, S ^a   Marmor, S M ^b   Goryainov, P ^a   Weinbroum, A A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cyclooxygenase 2; Ischemia reperfusion; Lung; Nitric oxide

Indexed keywords

CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ADULT; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG; LUNG INJURY; LUNG ISCHEMIA REPERFUSION INJURY; LUNG LAVAGE; LUNG PERFUSION; MALE; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; REPERFUSION INJURY;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CYCLOOXYGENASE 2; LUNG; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; REPERFUSION INJURY; UP-REGULATION;

EID: 84892691373     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.858196     Document Type: Article

References (34)

1. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL: Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299:H1283-H1299.
2. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND: Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med. 2009;179:220-227.
3. Hickey MJ, Granger DN, Kubes P: Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol Scand. 2001;173:119-126.
4. Kaminski A, Pohl CB, Sponholz C, Ma N, Stamm C, Vollmar B, Steinhoff G: Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. Am J Pathol. 2004;164:2241-2249.
5. Cobelens PM, van Putte BP, Kavelaars A, Heijnen CJ, Kesecioglu J: Inflammatory consequences of lung ischemia-reperfusion injury and low-pressure ventilation. J Surg Res. 2009;153:295-301.
6. HickeyMJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, Kubes P: Inducible nitric oxide synthasedeficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 1997;11:955-964.
7. Ovechkin AV, Lominadze D, Sedoris KC, Robinson TW, Tyagi SC, Roberts AM: Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem. 2007;113:1-12.
8. Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AM: Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol. 2005;99:2423-2432.
9. Roberts AM, Ovechkin AV, Mowbray JG, Robinson TW, Lominadze D: Effects of pulmonary ischemia-reperfusion on platelet adhesion in subpleural arterioles in rabbits. Microvasc Res. 2004;67:29-37.
10. Parviz M, Bousamra M, 2nd, Chammas JH, Birks EK, Presberg KW, Jacobs ER, Nelin LD: Effects of chronic pulmonary overcirculation on pulmonary vasomotor tone. Ann Thorac Surg. 1999;67:522-527.
11. Robertson BE, Warren JB, Nye PC: Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs. Exp Physiol. 1990;75:255-257.
12. Adnot S, Raffestin B, Eddahibi S: NO in the lung. Respir Physiol. 1995;101:109-120.
13. Poon BY, Raharjo E, Patel KD, Tavener S, Kubes P: Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity. Circulation. 2003;108: 1107-1112.
14. DrogeW: Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
15. Bolli R, Shinmura K, Tang XL, Kodani E, Xuan YT, Guo Y, Dawn B: Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res. 2002;55:506-519.
16. Kodani E, Xuan YT, Shinmura K, Takano H, Tang XL, Bolli R: Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol. 2002;283:H1943-H1957.
17. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, Bolli R: Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA. 2000;97:10197-10202.
18. Hide EJ, Ney P, Piper J, Thiemermann C, Vane JR: Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol. 1995;116:2435-2440.
19. Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC: Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 onmyocardial infarct size after coronary occlusion in conscious dogs. Circ Res. 1981;49:685-700.
20. Shinmura K, Nagai M, Tamaki K, Tani M, Bolli R: COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. Am J Physiol Heart Circ Physiol. 2002;283:H2534-H2543.
21. Thiemermann C, Zacharowski K: Selective activation of Etype prostanoid(3)-receptors reducesmyocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther. 2000;87:61-67.
22. Xiao CY, Hara A, Yuhki K, Fujino T, Ma H, Okada Y, Takahata O, Yamada T, Murata T, Narumiya S, Ushikubi F: Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation. 2001;104:2210-2215.
23. Sedoris KC, Gozal E, Ovechkin AV, Theile AR, Roberts AM: Interplay of endothelial and inducible nitric oxide synthases modulates the vascular response to ischaemia-reperfusion in the rabbit lung. Acta Physiol (Oxf). 2012 Mar;204: 331-343.
24. Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379-L399.
25. Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, Star RA: Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol. 1995 Aug;13:167-174.
26. Sherman TS, Chen Z, Yuhanna IS, Lau KS, Margraf LR, Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol. 1999;276(2 Pt 1):L383-L390.
27. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA. 1994;91:10089-10093.
28. Michel T, Feron O: Nitric oxide synthases: which, where, how, and why? J Clin Invest.1997, 100. 2146-2152.
29. Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, Okubo T: Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol. 1998;160:3031-3037.
30. LaPointe MC, Isenovic E: Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension. 1999;33(1 Pt 2):276-282.
31. Corbett JA, Kwon G, Turk J, McDaniel ML: IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry. 1993;32:13767-13770.
32. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C: Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA. 1998;95:10966-10971.
33. Serou MJ, DeCoster MA, Bazan NG: Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: plateletactivating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res. 1999;58:593-598.
34. Mgbemena V, Segovia JA, Chang TH, Tsai SY, Cole GT, Hung CY, Bose S: Transactivation of inducible nitric oxide synthase gene by Kruppel-like factor 6 regulates apoptosis during influenza A virus infection. J Immunol. 2012;189: 606-615.